Clinical Trials in Italy / NCT03416959
Recruiting
Observational
Bone Metastases Database of Patients Treated Surgically for Impending or Pathologic Fracture of Long Bones
NCT03416959 · tracked via the Priya Life Science Italy tracker
Condition(s) studied
Neoplasm Metastasis
Investigational drug(s) / intervention(s)
intramedullary fixation or endoprosthetic reconstruction
intramedullary fixation or endoprosthetic reconstruction: Surgical treatment for long bone metastases with intramedullary nail or endoprosthetic reconstruction
Study summary
The aims of this study are to collect prospective data on the natural history of bone metastases (BMs) and skeleta related events (SREs),
Eligibility
Inclusion Criteria:
* Patients with long bone metastases treated surgically with intramedullary nail or endoprosthetic reconstruction
Exclusion Criteria:
* Patients with bone metastases of the spine
Primary outcome measure(s)
- Clinical outcomes after treatment of long bone metastases with intramedullary nail versus endoprosthetic reconstruction — 24 months
The study includes the collection of clinical data (age, sex, Karnofsky score) and laboratory data related to the patient (erythrocyte sedimentation rate, C reactive protein, Alkaline phosphatase, white blood cells and hemoglobin) at the time of admission, data on the pathology (histotype, site of bone metastasis , presence of further skeletal or visceral metastases), type of surgery performed (stabilization versus resection).The objectives of this study is to examine clinical outcomes after after surgical treatment of bone metastases with a specific focus on differences in complication rate between patients treated with intramedullary nail versus endoprosthetic reconstruction
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Istituto Ortopedico Rizzoli | Bologna | Bologna | Recruiting |
More Istituto Ortopedico Rizzoli trials in Italy
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03416959 on ClinicalTrials.gov ↗ ← All trials in Italy